Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,590	5,260	4,342	5,044	5,333	-
Market Cap Growth	-12.31%	21.13%	-13.91%	-5.42%	-	-
Enterprise Value	3,677	4,347	3,260	3,905	3,860	-
Last Close Price	53.28	61.05	48.17	52.79	55.15	-
PE Ratio	30.45	34.56	36.98	46.03	36.53	-
Forward PE	22.53	27.56	31.74	22.50	30.12	-
PS Ratio	3.47	3.97	3.94	4.62	6.40	-
PB Ratio	2.29	2.63	2.14	2.41	2.57	-
P/TBV Ratio	2.30	2.63	2.15	2.42	2.57	-
P/FCF Ratio	-	-	62.06	-	-	-
P/OCF Ratio	-	-	27.43	-	178.53	-
EV/Sales Ratio	2.78	3.28	2.96	3.58	4.63	-
EV/EBITDA Ratio	17.65	20.86	26.38	35.88	25.71	-
EV/EBIT Ratio	18.62	22.01	28.92	39.33	26.74	-
EV/FCF Ratio	-	-	46.59	-	-	-
Debt / Equity Ratio	0.12	0.12	0.04	0.03	0.02	0.04
Debt / EBITDA Ratio	1.13	1.13	0.58	0.45	0.25	0.23
Debt / FCF Ratio	-	-	1.18	-	-	-
Net Debt / Equity Ratio	-0.46	-0.46	-0.54	-0.58	-0.71	-0.26
Net Debt / EBITDA Ratio	-4.38	-4.38	-8.89	-11.18	-9.78	-1.49
Net Debt / FCF Ratio	-	-	-15.70	10.27	172.02	1.76
Asset Turnover	-	-	0.46	0.46	0.51	0.86
Inventory Turnover	-	-	0.93	1.10	0.94	0.91
Quick Ratio	-	-	4.12	5.54	6.84	1.31
Current Ratio	-	-	6.39	8.22	9.01	3.28
Return on Equity (ROE)	7.55%	7.55%	5.71%	5.21%	10.79%	19.65%
Return on Assets (ROA)	-	-	2.92%	2.60%	5.53%	9.51%
Return on Invested Capital (ROIC)	14.08%	15.20%	9.93%	11.55%	22.92%	25.82%
Return on Capital Employed (ROCE)	-	-	5.40%	4.60%	6.80%	16.40%
Earnings Yield	3.32%	2.89%	2.70%	2.17%	2.74%	-
FCF Yield	-	-	1.61%	-2.35%	-0.16%	-
Dividend Yield	1.65%	-	1.87%	1.70%	1.99%	-
Payout Ratio	-	-	68.03%	91.29%	0.06%	0.19%
Buyback Yield / Dilution	2.23%	2.23%	1.76%	-22.83%	-10.09%	-8.03%
Total Shareholder Return	3.81%	2.23%	3.63%	-21.13%	-8.10%	-8.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.